-
BERLIN, GERMANY - Jun 17, 2019 -
New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
- Minimally-invasive blood test could complement colonoscopy in high-risk LS patients who are non-compliant with colonoscopy screening recommendations or may develop precancerous lesions in the interval between colonoscopies -
BERLIN, June 17, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the "Company"), a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology, today reported new study results suggesting that Epi proColon®, a colorectal cancer screening test approved for patients who are unwilling or unable to be screened by recommended methods may also be an important complement to colonoscopy for CRC screening in patients with LS, a hereditary disease associated with a 10-80% increase in the risk of developing CRC
Jun 17, 2019
-
PRINCETON, NJ - Jun 19, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp® physiologically-based pharmacokinetic (PBPK) modeling and simulation technology was used to demonstrate bioequivalence (BE) for the US Food and Drug Administration (FDA) approval of a complex generic drug on the agencys abbreviated new drug application (ANDA) pathway
Jun 12, 2019
-
HALIFAX, NS, CANADA - Jun 12, 2019 - Nova Scotia-based life sciences company Sona Nanotech Inc. has been named the Startup Canada Innovation Award winner for the Atlantic Canada region
Jun 12, 2019
-
GUILDFORD, UNITED KINGDOM - Jun 11, 2019 - The Amsterdam University Medical Center has won MR Solutions Image of the Year 2019 award for the best molecular research image
Jun 11, 2019
-
PRINCETON, NJ - Jun 10, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its scientists will participate in 28 sessions at the Population Approach Group in Europe (PAGE) 2019 Annual Meeting
Jun 10, 2019
-
RICHMOND, VA, UNITED STATES - Jun 6, 2019 -
RICHMOND, Va. (June 6, 2019)
- BRAINBox Solutions today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's BRAINBox TBI (Traumatic Brain Injury) test in development, the first to aid in both the diagnosis and prognosis of mild TBI (concussion)
Jun 6, 2019
-
SAN DIEGO, CA - Jun 4, 2019 - ~~San Diego, CA . . . . BINDING SITEs IMMUNOLOGICALS GROUP is pleased to announce the addition of two (2) new native Tick-Borne Encephalitis (TBE) viral antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
Jun 4, 2019
-
WESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7
Jun 3, 2019
-
GUILDFORD, UNITED KINGDOM - May 24, 2019 - MR Solutions high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last week
May 30, 2019
-
KIRKLAND, WA, UNITED STATES - May 30, 2019 - Resolution Bioscience, Inc., today announced that the Resolution HRD liquid biopsy assay has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA)
May 30, 2019
-
WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research
May 29, 2019
-
PRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data
May 28, 2019
-
MENLO PARK, CA - May 23, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today the addition of William F
May 23, 2019
-
SUFFERN, NY, UNITED STATES - May 18, 2019 - CDx Diagnostics®, innovator of the WATS3D® diagnostic tissue test for the detection and surveillance of Barretts esophagus (BE), a known precursor to esophageal adenocarcinoma (EAC), today announced positive results from a clinical study evaluating WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) in detecting residual/recurrent intestinal metaplasia (RRIM) in patients who have undergone BE ablation
May 21, 2019
-
NEWARK, CA, UNITED STATES - May 21, 2019 - NEWARK, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced results related to its seladelpar clinical development program for the treatment of primary biliary cholangitis (PBC)
May 21, 2019
-
PRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc
May 20, 2019
-
PRINCETON, NJ - May 16, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr
May 16, 2019
-
GUILDFORD, UK - May 14, 2019 - In a paper published in the American Chemical Society journal researchers from Bourgogne University showed that the use of superparamagnetic iron oxide nanoparticles (NPs) using multi modal – PET/MRI - showed promising improvements in imaging capabilities
May 14, 2019
-
WESTBURY, NY - May 2, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that its ADME-Tox team has co-authored a second peer-reviewed paper investigating the potential for clinically-relevant botanical-drug interactions (BDIs) with toxicology colleagues at The Procter & Gamble Company (P&G)
May 2, 2019
-
ROYAL OAK, MI, UNITED STATES - Apr 30, 2019 - OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests by harnessing the power of the immune system, today announced the appointment of Mark McDonough as its president, chief executive officer (CEO) and member of the Board of Directors
Apr 30, 2019